Mariner’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $304K | Sell |
26,694
-4,136
| -13% | -$47.1K | ﹤0.01% | 2716 |
|
2025
Q1 | $366K | Sell |
30,830
-886
| -3% | -$10.5K | ﹤0.01% | 2462 |
|
2024
Q4 | $598K | Sell |
31,716
-79
| -0.2% | -$1.49K | ﹤0.01% | 2041 |
|
2024
Q3 | $714K | Buy |
31,795
+231
| +0.7% | +$5.19K | ﹤0.01% | 1867 |
|
2024
Q2 | $659K | Buy |
31,564
+12
| +0% | +$250 | ﹤0.01% | 1830 |
|
2024
Q1 | $464K | Buy |
31,552
+13
| +0% | +$191 | ﹤0.01% | 2086 |
|
2023
Q4 | $325K | Sell |
31,539
-388
| -1% | -$4K | ﹤0.01% | 2258 |
|
2023
Q3 | $251K | Sell |
31,927
-779
| -2% | -$6.12K | ﹤0.01% | 2312 |
|
2023
Q2 | $327K | Sell |
32,706
-2,509
| -7% | -$25.1K | ﹤0.01% | 2054 |
|
2023
Q1 | $313K | Buy |
35,215
+4,812
| +16% | +$42.8K | ﹤0.01% | 2036 |
|
2022
Q4 | $334K | Buy |
30,403
+397
| +1% | +$4.36K | ﹤0.01% | 1941 |
|
2022
Q3 | $391K | Buy |
30,006
+109
| +0.4% | +$1.42K | ﹤0.01% | 1578 |
|
2022
Q2 | $379K | Buy |
29,897
+773
| +3% | +$9.8K | ﹤0.01% | 1221 |
|
2022
Q1 | $408K | Buy |
29,124
+106
| +0.4% | +$1.49K | ﹤0.01% | 1202 |
|
2021
Q4 | $840K | Buy |
29,018
+18
| +0.1% | +$521 | ﹤0.01% | 874 |
|
2021
Q3 | $869K | Buy |
+29,000
| New | +$869K | ﹤0.01% | 732 |
|